Ghent University Academic Bibliography

Advanced

LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European Atherosclerosis Society lipid goals.

E MULS, Gui De Backer UGent, Dirk De Bacquer UGent, M BROHET and F HELLER (2000) CLINICAL DRUG INVESTIGATION. 19(3). p.219-229
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
CLINICAL DRUG INVESTIGATION
volume
19
issue
3
pages
219-229 pages
Web of Science type
Article
Web of Science id
000086107600007
ISSN
1173-2563
language
English
UGent publication?
yes
classification
A1
id
127951
handle
http://hdl.handle.net/1854/LU-127951
date created
2004-01-14 13:36:00
date last changed
2016-12-19 15:38:54
@article{127951,
  author       = {MULS, E and De Backer, Gui and De Bacquer, Dirk and BROHET, M and HELLER, F},
  issn         = {1173-2563},
  journal      = {CLINICAL DRUG INVESTIGATION},
  language     = {eng},
  number       = {3},
  pages        = {219--229},
  title        = {LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European Atherosclerosis Society lipid goals.},
  volume       = {19},
  year         = {2000},
}

Chicago
MULS, E, Gui De Backer, Dirk De Bacquer, M BROHET, and F HELLER. 2000. “LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals.” Clinical Drug Investigation 19 (3): 219–229.
APA
MULS, E., De Backer, G., De Bacquer, D., BROHET, M., & HELLER, F. (2000). LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European Atherosclerosis Society lipid goals. CLINICAL DRUG INVESTIGATION, 19(3), 219–229.
Vancouver
1.
MULS E, De Backer G, De Bacquer D, BROHET M, HELLER F. LIPI-WATCH, a Belgian/Luxembourg survey on achievement of European Atherosclerosis Society lipid goals. CLINICAL DRUG INVESTIGATION. 2000;19(3):219–29.
MLA
MULS, E, Gui De Backer, Dirk De Bacquer, et al. “LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals.” CLINICAL DRUG INVESTIGATION 19.3 (2000): 219–229. Print.